Anti-PD-L1 agent
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Anti-PD-L1 agent, covering 2024-03-22 to 2024-03-22. Get the full timeline:
Most recent: Clinical Trial Update: Study of Anti-PD-L1 in Combination With Chemo(Radio)Therapy for Oesophageal Cancer [Phase 1, Phase 2]